Page last updated: 2024-08-24

nelfinavir and Dyslipidemia

nelfinavir has been researched along with Dyslipidemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukushima, K; Haraya, K; Ito, Y; Sugioka, N; Takada, K	1
Dubé, MP; Grinspoon, SK; Meyer, WA; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Shafer, RW; Snyder, SW; Tebas, P; Wininger, DA; Zackin, RA	1

Trials

1 trial(s) available for nelfinavir and Dyslipidemia

Article	Year
Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS (London, England), 2005, Nov-04, Volume: 19, Issue:16 Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Blood Glucose; Cyclopropanes; Drug Therapy, Combination; Dyslipidemias; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Lipids; Male; Nelfinavir; Nucleosides; Oxazines	2005

Article

Year

Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides.

AIDS (London, England), 2005, Nov-04, Volume: 19, Issue:16

Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Blood Glucose; Cyclopropanes; Drug Therapy, Combination; Dyslipidemias; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Insulin Resistance; Lipids; Male; Nelfinavir; Nucleosides; Oxazines

2005

Other Studies

1 other study(ies) available for nelfinavir and Dyslipidemia

Article	Year
Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats. Biopharmaceutics & drug disposition, 2009, Volume: 30, Issue:9 Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Dietary Fats; Drug Monitoring; Dyslipidemias; Fatty Liver; HIV Protease Inhibitors; Intestinal Mucosa; Male; Metabolic Syndrome; Nelfinavir; Obesity; Rats; Rats, Wistar; Tissue Distribution	2009

Article

Year

Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats.

Biopharmaceutics & drug disposition, 2009, Volume: 30, Issue:9

Topics: Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile; Dietary Fats; Drug Monitoring; Dyslipidemias; Fatty Liver; HIV Protease Inhibitors; Intestinal Mucosa; Male; Metabolic Syndrome; Nelfinavir; Obesity; Rats; Rats, Wistar; Tissue Distribution

2009